Jazz Pharmaceuticals
JAZZ
#1899
Rank
$10.31 B
Marketcap
$169.70
Share price
1.67%
Change (1 day)
38.43%
Change (1 year)

Jazz Pharmaceuticals (JAZZ) - Net assets

Net assets on the balance sheet as of September 2025 : $3.95 Billion USD

According to Jazz Pharmaceuticals's latest financial reports the company has $3.95 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jazz Pharmaceuticals - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$4.09 B9.55%
2023-12-31$$3.73 B21.11%
2022-12-31$$3.08 B-22.18%
2021-12-31$$3.96 B8.35%
2020-12-31$$3.65 B17.64%
2019-12-31$$3.11 B12.82%
2018-12-31$$2.75 B1.63%
2017-12-31$$2.71 B44.52%
2016-12-31$$1.87 B17.43%
2015-12-31$$1.59 B16.59%
2014-12-31$$1.37 B5.84%
2013-12-31$$1.29 B15.54%
2012-12-31$$1.12 B481.62%
2011-12-31$$0.19 B531.04%
2010-12-31$$30.55 M-141.95%
2009-12-31$-$72.83 Million-21.59%
2008-12-31$-$92.88 Million-268.89%
2007-12-31$$54.99 M-131.19%
2006-12-31$-$0.18 Billion49.09%
2005-12-31$-$0.12 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Endo International
ENDPQ
-$6.6 Billion-266.65%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
$0.92 B-76.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$44.75 B 1,030.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
$7.25 B 83.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel